추천 제품
product name
Ascentis® Express Peptide ES-C18, 2.7 μm HPLC Column, 2.7 μm particle size, L × I.D. 5 cm × 2.1 mm
material
stainless steel column
Quality Level
Agency
suitable for USP L1
제품 라인
Ascentis®
특징
endcapped: no
제조업체/상표
Ascentis®
포장
1 ea of
파라미터
≤100 °C temp. range
600 bar max. pressure (9000 psi)
기술
HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable
길이 × I.D.
5 cm × 2.1 mm
표면적
90 m2/g
불순물
<5 ppm metals
기질
Fused-Core particle platform
superficially porous particle
기질 활성군
C18 (octadecyl) phase
입자 크기
2.7 μm
공극 크기
160 Å
operating pH range
1-9
분리 기술
reversed phase
유사한 제품을 찾으십니까? 방문 제품 비교 안내
일반 설명
Ascentis Express Peptide ES-C18 columns are specifically engineered to separate higher molecular weight compounds such as peptides and small proteins. These columns contain advanced Fused-Core particles that have larger pores (160 Å versus 90 Å in standard Ascentis Express), bonded with sterically-protected C18 ligands to provide extra stability (ES) at very low pH (< 1) and high temperatures (up to 100ºC). This greatly expands the application range for Ascentis Express columns.
법적 정보
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
가아드 카트리지
관련 제품
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
시험 성적서(COA)
Lot/Batch Number
Meiyun Shi et al.
Journal of separation science, 38(8), 1351-1357 (2015-01-30)
The pentapeptide thymopentin (Arg-Lys-Asp-Val-Tyr, RKDVY) corresponds to amino acids 32-36 of the 49 amino acid immunomodulatory polypeptide, thymopoietin, whose biological activity is partially reproduced. Thymopentin is widely used in the clinic and represents a promising target for drug design but
E Lesellier
Journal of chromatography. A, 1266, 34-42 (2012-11-03)
The recent introduction of new stationary phases for liquid chromatography based on superficially porous particles, called core-shell or fused-core, dramatically improved the separation performances through very high efficiency, due mainly to reduced eddy diffusion. However, few studies have evaluated the
C Gröer et al.
Journal of pharmaceutical and biomedical analysis, 100, 393-401 (2014-09-15)
Cytochrome P450 (CYP) enzymes and UDP-glucuronosyltransferases (UGT) are major determinants in the pharmacokinetics of most drugs on the market. To investigate their impact on intestinal and hepatic drug metabolism, we developed and validated quantification methods for nine CYP (CYP1A2, CYP2B6
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.